Cellectar Biosciences, Inc.

US$1.25As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CLRBHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (56.74%)
Div yield —
ROE (119.57%)
Biotechnology
Beta (5Y) 0.63
PE TTM —
TSR TTM (63.13%)
Mkt cap US$11.82M
ROIC (74.80%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.49
18.81%
(88.26%)
Hold 4|0|12|4|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.02
0.02
0.02
5.55%
17.11%
21.19%
22.56%
Revenue$M
1.386
1.467
1.554
1.575
17.55%
22.26%
24.22%
19.45%
Peers (US$11.82M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.717
(0.236)
(0.221)
EBIT/Intx
2.610
0.121
0.148
Own earn%
(79.75)
128.87
101.25
Sh yield%
18.01
62.29
62.09
Owners
Insiders/Inst%
1.94
26.94
Short interest%
3.81
SBC / revenue%
3.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
8–15
$1 testx
−0.2
Incr. ROIC%
2